Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
A Genome-Wide Association Study Identifies Novel Loci for Paclitaxel-Induced Sensory Peripheral Neuropathy in CALGB 40101
2012
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
2016 Standout
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973–1995
2002
Genetic Polymorphisms in Organic Cation Transporter 1 Attenuates Hepatic Metformin Exposure in Humans
2017
Global patterns and trends in colorectal cancer incidence and mortality
2016 Standout
Antibiotics in early life and obesity
2014
The Additive Effects of the Active Component of Grapefruit Juice (Naringenin) and Antiarrhythmic Drugs on HERG Inhibition
2007
Effect of the CYP2C8 Genotype on the Pharmacokinetics and Pharmacodynamics of Repaglinide
2011
Some Aspects of Genetic Polymorphism in the Biotransformation of Antidepressants
2004
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
Alternatives to amphotericin B for Candida rugosa infection
2004
Oral Erythromycin and the Risk of Sudden Death from Cardiac Causes
2004
Drugs as CYP3A Probes, Inducers, and Inhibitors
2007
Risk factors for Barrett’s oesophagus and oesophageal adenocarcinoma: Results from the FINBAR study
2007
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Global Cancer Statistics, 2002
2005 Standout
Polymorphism of human cytochrome P450 enzymes and its clinical impact
2009
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis
2010
Identifying intestinal metaplasia at the squamocolumnar junction by using optical coherence tomography
2006
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma
2002
Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
2009
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
2019 Standout
Temporal Trends (1973–1997) in Survival of Patients With Esophageal Adenocarcinoma in The United States: A Glimmer of Hope?
2003
Screening for Barrett’s esophagus in colonoscopy patients with and without heartburn
2003
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function
2012
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Management of Barrett's Esophagus: A National Study of Practice Patterns and Their Cost Implications
1999
Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death
2009
The Influence of Age and Sex on the Clearance of Cytochrome P450 3A Substrates
2005
Antibiotic development — economic, regulatory and societal challenges
2019 Standout
Esophageal Cancer
2003 Standout
Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries
2018
The mechanisms of action of metformin
2017 Standout
Colorectal cancer
2013 Standout
Data Resource Profile: The Danish National Prescription Registry
2016 Standout
In Vivo Imaging of Human 11 C-Metformin in Peripheral Organs: Dosimetry, Biodistribution, and Kinetic Analyses
2016
Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects
2007
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics
2011
The Incidence of Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Barrett's Esophagus Makes a Difference
2005
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
2014 Standout
Colorectal cancer
2019 Standout
Epidemiology of gastro-oesophageal reflux disease: a systematic review
2005 Standout
Global cancer statistics
2011 Standout
Colorectal cancers in ulcerative colitis from a low-prevalence area for colon cancer
2015
Using Raman spectroscopy to characterize biological materials
2016 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Utilising non-consensus pathology measurements to improve the diagnosis of oesophageal cancer using a Raman spectroscopic probe
2013
Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort Studies
2012
Lack of Evidence of a Clopidogrel–Statin Interaction in the CHARISMA Trial
2007
Oesophageal carcinoma
2013 Standout
Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer)
2006
The Role of Human CYP2C8 and CYP2C9 Variants in Pioglitazone MetabolismIn Vitro
2009
Cytochrome P450 3A Inhibition by Ketoconazole Affects Prasugrel and Clopidogrel Pharmacokinetics and Pharmacodynamics Differently
2007
Clopidogrel–Drug Interactions
2011
Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
1999 Standout
Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2
2009
The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus
2006 Standout
Long-Term Survival After Esophagectomy for Barrett's Adenocarcinoma in Endoscopically Surveyed and Nonsurveyed Patients
2002
CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel
2013
β-Lactams and β-Lactamase Inhibitors: An Overview
2016 Standout
Gastroesophageal Reflux, Barrett Esophagus, and Esophageal Cancer
2002
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Trimethoprim and the CYP2C8*3 Allele Have Opposite Effects on the Pharmacokinetics of Pioglitazone
2007
Ulcerative colitis
2020 Standout
Metformin and the gastrointestinal tract
2016
Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus
2008 Standout
Global Patterns of Cancer Incidence and Mortality Rates and Trends
2010 Standout
The infant microbiome development: mom matters
2014
Clonal evolution in cancer
2012 StandoutNature
The pharmacogenetics of metformin
2017
Incidence of Adenocarcinoma among Patients with Barrett's Esophagus
2011
Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs
2004
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping
2007
Pharmacokinetics and pharmacodynamics of rosiglitazone in relation to CYP2C8 genotype
2006
Continuing Rapid Increase in Esophageal Adenocarcinoma in England and Wales
2008
Clinically Significant Drug Interactions with Newer Antidepressants
2011
Gut microbiota in human metabolic health and disease
2020 Standout
Altered Stress-Induced Cortisol Levels in Goats Exposed to Polychlorinated Biphenyls (PCB 126 and PCB 153) During Fetal and Postnatal Development
2009
The human skin microbiome
2018 Standout
Risk factors for Barrett's esophagus: A case‐control study
2001
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or 4
2018
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Chemotherapy‐induced peripheral neurotoxicity: A critical analysis
2013
Cytochrome P450 2C8 Pharmacogenetics: A Review of Clinical Studies
2009
Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study
2014
Surveillance and survival in Barrett's adenocarcinomas: A population-based study
2002
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Worldwide Incidence of Colorectal Cancer, Leukemia, and Lymphoma in Inflammatory Bowel Disease: An Updated Systematic Review and Meta-Analysis
2016
A Survey of Canadian Gastroenterologists about the Management of Barrett’s Esophagus
2003
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota
2017 Standout
Canadian Consensus Conference on the Management of Gastroesophageal Reflux Disease in Adults – Update 2004
2005
Pharmacogenomics of Oral Antidiabetic Medications: Current Data and Pharmacoepigenomic Perspective
2011
A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle
2010 StandoutNobel
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease
2006
Epidemiology of Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third
2009
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Part 14: Pediatric Advanced Life Support
2010 Standout
Personalized Therapy in Pain Management: Where Do We Stand?
2010
Works of Per Damkier being referenced
Effect of fluvoxamine on the pharmacokinetics of quinidine
1999
Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers
2006
The antiplatelet effect of clopidogrel is not attenuated by statin treatment in stable patients with ischemic heart disease
2005
The impact ofCYP2C8polymorphism and grapefruit juice on the pharmacokinetics of repaglinide
2005
Existence of a Clinically Relevant Interaction between Clopidogrel and HMG‐CoA Reductase Inhibitors? Re‐evaluating the Evidence
2005
Escitalopram Is a Weak Inhibitor of the CYP2D6-Catalyzed O-Demethylation of (+)-Tramadol but Does Not Reduce the Hypoalgesic Effect in Experimental Pain
2009
First-Trimester Exposure to Methylphenidate
2014
A gene–gene interaction between polymorphisms in the OCT2 and MATE1 genes influences the renal clearance of metformin
2013
A Comparative Pharmacokinetic Study in Healthy Volunteers of the Effect of Carbamazepine and Oxcarbazepine on Cyp3a4
2007
Tramadol as a new probe for cytochrome P450 2D6 phenotyping: A population study
2005
Use of Antibiotics in Children
2014
The effects of human CYP2C8 genotype and fluvoxamine on the pharmacokinetics of rosiglitazone in healthy subjects
2006
Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer
2011
Steady-state pharmacokinetics of metformin is independent of the OCT1 genotype in healthy volunteers
2015
Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer
2010
Impact ofABCB1Variants on Neutrophil Depression: A Pharmacogenomic Study of Paclitaxel in 92 Women with Ovarian Cancer
2011
Caffeine N3-demethylation (CYP1A2) in a population with an increased exposure to polychlorinated biphenyls
2006
Quinidine as a probe for CYP3A4 activity: Intrasubject variability and lack of correlation with probe-based assays for CYP1A2, CYP2C9, CYP2C19, and CYP2D6
2000
Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine
1999
Impact of CYP2C19 phenotypes on escitalopram metabolism and an evaluation of pupillometry as a serotonergic biomarker
2009
The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c
2011
Endogenous glucose production increases in response to metformin treatment in the glycogen-depleted state in humans: a randomised trial
2015
Adenocarcinoma of the Esophagus and Barrett's Esophagus: A Population-Based Study
1999
Generic switching of warfarin and risk of excessive anticoagulation: a Danish nationwide cohort study
2015
Increasing use of antibiotics in pregnancy during the period 2000–2010: prevalence, timing, category, and demographics
2014
Polychlorinated biphenyl (PCB) induction of CYP3A4 enzyme activity in healthy Faroese adults
2007
Survival and Incidence of Colorectal Cancer in Patients with Ulcerative Colitis in Funen County Diagnosed between 1973 and 1993
2000